The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs
Abstract
The subject of crystal engineering started in the 1970s with the study of topochemical reactions in the solid state. A broad chemical definition of crystal engineering was published in 1989, and the supramolecular synthon concept was proposed in 1995 followed by heterosynthons and their potential applications for the design of pharmaceutical cocrystals in 2004. This review traces the development of supramolecular synthons as robust and recurring hydrogen bond patterns for the design and construction of supramolecular architectures, notably, pharmaceutical cocrystals beginning in the early 2000s to the present time. The ability of a cocrystal between an active pharmaceutical ingredient (API) and a pharmaceutically acceptable coformer to systematically tune the physicochemical properties of a drug (i.e., solubility, permeability, hydration, color, compaction, tableting, bioavailability) without changing its molecular structure is the hallmark of the pharmaceutical cocrystals platform, as a bridge between drug discovery and pharmaceutical development. With the design of cocrystals via heterosynthons and prototype case studies to improve drug solubility in place (2000-2015), the period between 2015 to the present time has witnessed the launch of several salt-cocrystal drugs with improved efficacy and high bioavailability. This review on the design, synthesis, and applications of pharmaceutical cocrystals to afford improved drug products and drug substances will interest researchers in crystal engineering, supramolecular chemistry, medicinal chemistry, process development, and pharmaceutical and materials sciences. The scale-up of drug cocrystals and salts using continuous manufacturing technologies provides high-value pharmaceuticals with economic and environmental benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cambridge Structural Database
Groom, C. R., Bruno, I. J., Lightfoot, M. P., & Ward, S. C. (2016) · Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials · doi:10.1107/s2052520616003954 · Cited by 10,297
Supramolecular Chemistry: Concepts and Perspectives
Lehn, J. (1995) · Wiley eBooks · doi:10.1002/3527607439 · Cited by 9,864
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis
Desiraju, G. R. (1995) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199523111 · Cited by 4,856
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Encoding and decoding hydrogen-bond patterns of organic compounds
Etter, M. C. (1990) · Accounts of Chemical Research · doi:10.1021/ar00172a005 · Cited by 4,591
Cavallo, G., Metrangolo, P., Milani, R., Pilati, T., Priimagi, A., Resnati, G., & Terraneo, G. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00484 · Cited by 4,035
Hansen Solubility Parameters: A User's Handbook, Second Edition
Hansen, C. M. (2007) · CRC Press eBooks · doi:10.1201/9781420006834 · Cited by 3,156
Photodimerization in the solid state
Schmidt, G. M. J. (1971) · Pure and Applied Chemistry · doi:10.1351/pac197127040647 · Cited by 2,095
Hydrogen Bridges in Crystal Engineering: Interactions without Borders
Desiraju, G. R. (2002) · Accounts of Chemical Research · doi:10.1021/ar010054t · Cited by 2,057
The Hitchhiker’s Guide to Flow Chemistry
Plutschack, M. B., Pieber, B., Gilmore, K., & Seeberger, P. H. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00183 · Cited by 1,995
Definition of the halogen bond (IUPAC Recommendations 2013).
Desiraju, G. R., Ho, P. S., Kloo, L., Legon, A. C., Marquardt, R., Metrangolo, P., Politzer, P., Resnati, G., & Rissanen, K. (2013) · Pure and Applied Chemistry · doi:10.1351/pac-rec-12-05-10 · Cited by 1,957
Definition of the hydrogen bond (IUPAC Recommendations 2011)
Arunan, E., Desiraju, G. R., Klein, R. A., Sadlej, J., Scheiner, S., Alkorta, I., Clary, D. C., Crabtree, R. H., Dannenberg, J. J., Hobza, P., et al. (2011) · Pure and Applied Chemistry · doi:10.1351/pac-rec-10-01-02 · Cited by 1,886
Continuous‐Flow Technology—A Tool for the Safe Manufacturing of Active Pharmaceutical Ingredients
Gutmann, B., Cantillo, D., & Kappe, C. O. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201409318 · Cited by 1,469
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
Blagden, N., de Matas, M., Gavan, P. T., & York, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.011 · Cited by 1,448
Designed Multiple Ligands. An Emerging Drug Discovery Paradigm
Morphy, R., & Rankovic, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,209
Quantifying Intermolecular Interactions: Guidelines for the Molecular Recognition Toolbox
Hunter, C. A. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200301739 · Cited by 1,097
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
Babu, N. J., & Nangia, A. (2011) · Crystal Growth & Design · doi:10.1021/cg200492w · Cited by 1,004
Self-citationVishweshwar, P., McMahon, J. A., Bis, J. A., & Zaworotko, M. J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20578 · Cited by 968
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Brouwers, J., Brewster, M. E., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21650 · Cited by 947
On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system
Adamo, A., Beingessner, R. L., Behnam, M., Chen, J., Jamison, T. F., Jensen, K. F., Monbaliu, J.-C. M., Myerson, A. S., Revalor, E. M., Snead, D. R., et al. (2016) · Science · doi:10.1126/science.aaf1337 · Cited by 941
Halogen Bonds in Crystal Engineering: Like Hydrogen Bonds yet Different
Mukherjee, A., Tothadi, S., & Desiraju, G. R. (2014) · Accounts of Chemical Research · doi:10.1021/ar5001555 · Cited by 940
Pharmaceutical cocrystals: along the path to improved medicines
Duggirala, N. K., Perry, M. L., Almarsson, Ö., & Zaworotko, M. J. (2016) · Chemical Communications · doi:10.1039/c5cc08216a · Cited by 928
The Halogen Bond in the Design of Functional Supramolecular Materials: Recent Advances
Priimagi, A., Cavallo, G., Metrangolo, P., & Resnati, G. (2013) · Accounts of Chemical Research · doi:10.1021/ar400103r · Cited by 881
Dunitz, J. D., & Bernstein, J. (1995) · Accounts of Chemical Research · doi:10.1021/ar00052a005 · Cited by 843
Pharmaceutical Applications of Hot-Melt Extrusion: Part I
Crowley, M. M., Zhang, F., Repka, M. A., Thumma, S., Upadhye, S. B., Kumar Battu, S., McGinity, J. W., & Martin, C. (2007) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040701498759 · Cited by 824
Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2142 · Cited by 818
Supramolecular gelling agents: can they be designed?
Dastidar, P. (2008) · Chemical Society Reviews · doi:10.1039/b807346e · Cited by 791
Cabeza, A. J. C., & Bernstein, J. (2013) · Chemical Reviews · doi:10.1021/cr400249d · Cited by 774
Gilli, P., Pretto, L., Bertolasi, V., & Gilli, G. (2009) · Accounts of Chemical Research · doi:10.1021/ar800001k · Cited by 744
Müller, R. H., Gohla, S., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.007 · Cited by 702
Solubility parameters as predictors of miscibility in solid dispersions
Greenhalgh, D. J., Williams, A. C., Timmins, P., & York, P. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9900856 · Cited by 674
Acid–base crystalline complexes and the pKa rule
Cruz-Cabeza, A. J. (2012) · CrystEngComm · doi:10.1039/c2ce26055g · Cited by 673
Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications
Karimi-Jafari, M., Padrela, L., Walker, G. M., & Croker, D. M. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b00933 · Cited by 667
Friščić, T., Childs, S. L., Rizvi, S. A. A., & Jones, W. (2009) · CrystEngComm · doi:10.1039/b815174a · Cited by 649
Supramolecular gel chemistry: developments over the last decade
Steed, J. W. (2011) · Chem. Commun. · doi:10.1039/c0cc03293j · Cited by 640
Mascia, S., Heider, P. L., Zhang, H., Lakerveld, R., Benyahia, B., Barton, P. I., Braatz, R. D., Cooney, C. L., Evans, J. M. B., Jamison, T. F., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201305429 · Cited by 599
383. Topochemistry. Part I. A survey
Cohen, M. D., & Schmidt, G. M. J. (1964) · Journal of the Chemical Society (Resumed) · doi:10.1039/jr9640001996 · Cited by 594
Report on the sixth blind test of organic crystal structure prediction methods
Reilly, A. M., Cooper, R. I., Adjiman, C. S., Bhattacharya, S., Boese, A. D., Brandenburg, J. G., Bygrave, P. J., Bylsma, R., Campbell, J. E., Car, R., et al. (2016) · Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials · doi:10.1107/s2052520616007447 · Cited by 584
Yan, D., Delori, A., Lloyd, G. O., Friščić, T., Day, G. M., Jones, W., Lu, J., Wei, M., Evans, D. G., & Duan, X. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201106391 · Cited by 534
Handbook of Pharmaceutical Salts: Properties, Selection, and Use
(2002) · Chemistry International -- Newsmagazine for IUPAC · doi:10.1515/ci.2002.24.3.20a · Cited by 532
Hansen solubility parameter as a tool to predict cocrystal formation
Mohammad, M. A., Alhalaweh, A., & Velaga, S. P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.030 · Cited by 529
Ionic liquids for energy, materials, and medicine
Smiglak, M., Pringle, J. M., Lu, X., Han, L., Zhang, S., Gao, H., MacFarlane, D. R., & Rogers, R. D. (2014) · Chem. Commun. · doi:10.1039/c4cc02021a · Cited by 509
Orthogonal Multipolar Interactions in Structural Chemistry and Biology
Paulini, R., Müller, K., & Diederich, F. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462213 · Cited by 505
Crystal Engineering: A Textbook
Desiraju, G. R., Vittal, J. J., & Ramanan, A. (2011) · Co-Published with Indian Institute of Science (IISc), Bangalore, India eBooks · doi:10.1142/8060 · Cited by 498
Mechanochemical preparation of co-crystals
Braga, D., Maini, L., & Grepioni, F. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60014a · Cited by 492
Economic Analysis of Integrated Continuous and Batch Pharmaceutical Manufacturing: A Case Study
Schaber, S. D., Gerogiorgis, D. I., Ramachandran, R., Evans, J. M. B., Barton, P. I., & Trout, B. L. (2011) · Industrial & Engineering Chemistry Research · doi:10.1021/ie2006752 · Cited by 484
Berge, S. M., Bighley, L. D., & Monkhouse, D. C. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660104 · Cited by 479
Prediction of Hansen Solubility Parameters with a New Group-Contribution Method
Stefanis, E., & Panayiotou, C. (2008) · International Journal of Thermophysics · doi:10.1007/s10765-008-0415-z · Cited by 478
Day, G. M., Cooper, T. G., Cruz-Cabeza, A. J., Hejczyk, K. E., Ammon, H. L., Boerrigter, S. X. M., Tan, J. S., Della Valle, R. G., Venuti, E., Jose, J., et al. (2009) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768109004066 · Cited by 436
Towards crystal structure prediction of complex organic compounds – a report on the fifth blind test
Bardwell, D. A., Adjiman, C. S., Arnautova, Y. A., Bartashevich, E., Boerrigter, S. X. M., Braun, D. E., Cruz-Cabeza, A. J., Day, G. M., Della Valle, R. G., Desiraju, G. R., et al. (2011) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768111042868 · Cited by 422
Ionic Liquids in Pharmaceutical Applications
Marrucho, I. M., Branco, L. C., & Rebelo, L. P. N. (2014) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-060713-040024 · Cited by 406
Sarma, J. A. R. P., & Desiraju, G. R. (1986) · Accounts of Chemical Research · doi:10.1021/ar00127a005 · Cited by 396
Disappearing Polymorphs Revisited
Bučar, D., Lancaster, R. W., & Bernstein, J. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410356 · Cited by 395
Structural Competition between Hydrogen Bonds and Halogen Bonds
Aakeröy, C. B., Fasulo, M., Schultheiss, N., Desper, J., & Moore, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073201c · Cited by 394
Pharmaceutical Cocrystals: An Emerging Approach to Physical Property Enhancement
Jones, W., Motherwell, W. D. S., & Trask, A. V. (2006) · MRS Bulletin · doi:10.1557/mrs2006.206 · Cited by 393
Cocrystals of Quercetin with Improved Solubility and Oral Bioavailability
Smith, A. J., Kavuru, P., Wojtas, L., Zaworotko, M. J., & Shytle, R. D. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200209j · Cited by 390
Guzmán, H. R., Tawa, M., Zhang, Z., Ratanabanangkoon, P., Shaw, P., Gardner, C. R., Chen, H., Moreau, J., Almarsson, Ö., & Remenar, J. F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20906 · Cited by 381
Liquid‐Assisted Grinding Mechanochemistry in the Synthesis of Pharmaceuticals
Ying, P., Yu, J., & Su, W. (2021) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202001245 · Cited by 368
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
Perspectives in Supramolecular Chemistry: The Crystal as a Supramolecular Entity
(1996) · Perspectives in Supramolecular Chemistry · doi:10.1002/9780470511459 · Cited by 353
The role of co-crystals in pharmaceutical design
Steed, J. W. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.12.003 · Cited by 341
Pharmaceutical cocrystals: from serendipity to design to application
Kavanagh, O. N., Croker, D. M., Walker, G. M., & Zaworotko, M. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.023 · Cited by 323
Paulekuhn, G. S., Dressman, J. B., & Saal, C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701032y · Cited by 304
Anion-switchable supramolecular gels for controlling pharmaceutical crystal growth
Foster, J. A., Piepenbrock, M.-O. M., Lloyd, G. O., Clarke, N., Howard, J. A. K., & Steed, J. W. (2010) · Nature Chemistry · doi:10.1038/nchem.859 · Cited by 299
Kilogram-scale prexasertib monolactate monohydrate synthesis under continuous-flow CGMP conditions
Cole, K. P., Groh, J. M., Johnson, M. D., Burcham, C. L., Campbell, B. M., Diseroad, W. D., Heller, M. R., Howell, J. R., Kallman, N. J., Koenig, T. M., et al. (2017) · Science · doi:10.1126/science.aan0745 · Cited by 298
Eutectics as improved pharmaceutical materials: design, properties and characterization
Cherukuvada, S., & Nangia, A. (2014) · Chem. Commun. · doi:10.1039/c3cc47521b · Cited by 296
Self-citationCrystal Engineering: An Outlook for the Future
Nangia, A. K., & Desiraju, G. R. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201811313 · Cited by 288
Self-citationA Million Crystal Structures: The Whole Is Greater than the Sum of Its Parts
Taylor, R., & Wood, P. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00155 · Cited by 280
Cinčić, D., Friščić, T., & Jones, W. (2008) · Chemistry – A European Journal · doi:10.1002/chem.200701184 · Cited by 261
Fast Dissolving Curcumin Cocrystals
Sanphui, P., Goud, N. R., Khandavilli, U. B. R., & Nangia, A. (2011) · Crystal Growth & Design · doi:10.1021/cg200704s · Cited by 253
Self-citationPolymorphism, what it is and how to identify it: a systematic review
Brog, J.-P., Chanez, C.-L., Crochet, A., & Fromm, K. M. (2013) · RSC Advances · doi:10.1039/c3ra41559g · Cited by 247
Banerjee, R., Bhatt, P. M., Ravindra, N. V., & Desiraju, G. R. (2005) · Crystal Growth & Design · doi:10.1021/cg050125l · Cited by 243
Senni, M., McMurray, J. J. V., Wachter, R., McIntyre, H. F., Reyes, A., Majercak, I., Andreka, P., Shehova-Yankova, N., Anand, I., Yilmaz, M. B., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.548 · Cited by 236
Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5
Kuminek, G., Cao, F., Bahia de Oliveira da Rocha, A., Gonçalves Cardoso, S., & Rodríguez-Hornedo, N. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.022 · Cited by 230
Engineering Cocrystals of Poorly Water-Soluble Drugs to Enhance Dissolution in Aqueous Medium
Sathisaran, I., & Dalvi, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030108 · Cited by 227
Melt extrusion with poorly soluble drugs – An integrated review
Repka, M. A., Bandari, S., Kallakunta, V. R., Vo, A. Q., McFall, H., Pimparade, M. B., & Bhagurkar, A. M. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.056 · Cited by 224
Vishweshwar, P., Nangia, A., & Lynch, V. M. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo0162484 · Cited by 221
Self-citationHAGEDORN, H. C. (1936) · Journal of the American Medical Association · doi:10.1001/jama.1936.02770030007002 · Cited by 221
Bak, A., Gore, A., Yanez, E., Stanton, M., Tufekcic, S., Syed, R., Akrami, A., Rose, M., Surapaneni, S., Bostick, T., et al. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21280 · Cited by 218
Onoue, S., Takahashi, H., Kawabata, Y., Seto, Y., Hatanaka, J., Timmermann, B., & Yamada, S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21964 · Cited by 206
Advances in coamorphous drug delivery systems
Shi, Q., Moinuddin, S. M., & Cai, T. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.08.002 · Cited by 201
Integrated Continuous Pharmaceutical Technologies—A Review
Domokos, A., Nagy, B., Szilágyi, B., Marosi, G., & Nagy, Z. K. (2021) · Organic Process Research & Development · doi:10.1021/acs.oprd.0c00504 · Cited by 183
Bioavailability of indomethacin-saccharin cocrystals
Jung, M.-S., Kim, J.-S., Kim, M.-S., Alhalaweh, A., Cho, W., Hwang, S.-J., & Velaga, S. P. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01189.x · Cited by 171
Pharmaceutical Cocrystals: Molecules, Crystals, Formulations, Medicines
Yousef, M. A. E., & Vangala, V. R. (2019) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b01898 · Cited by 169
Thakuria, R., & Sarma, B. (2018) · Crystals · doi:10.3390/cryst8020101 · Cited by 165
Self-citationAitipamula, S., Chow, P. S., & Tan, R. B. H. (2009) · CrystEngComm · doi:10.1039/b904616j · Cited by 157
Ramamurty, U., & Jang, J. (2013) · CrystEngComm · doi:10.1039/c3ce41266k · Cited by 157
Mechanochemistry: A Green Approach in the Preparation of Pharmaceutical Cocrystals
Solares-Briones, M., Coyote-Dotor, G., Páez-Franco, J. C., Zermeño-Ortega, M. R., Contreras, C. M. D. L. O., Canseco‐González, D., Avila‐Sorrosa, A., Morales‐Morales, D., & Germán-Acacio, J. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060790 · Cited by 156
Encapsulated Nanodroplet Crystallization of Organic-Soluble Small Molecules
Tyler, A. R., Ragbirsingh, R., McMonagle, C. J., Waddell, P. G., Heaps, S. E., Steed, J. W., Thaw, P., Hall, M. J., & Probert, M. R. (2020) · Chem · doi:10.1016/j.chempr.2020.04.009 · Cited by 153
Curcumin: pharmaceutical solids as a platform to improve solubility and bioavailability
Suresh, K., & Nangia, A. K. (2018) · CrystEngComm · doi:10.1039/c8ce00469b · Cited by 152
Self-citationPoechlauer, P., Colberg, J. C., Fisher, E., Jansen, M., Johnson, M. D., Koenig, S. G., Lawler, M., LaPorte, T. L., Manley, J. B., Martin, B. R., et al. (2013) · Organic Process Research & Development · doi:10.1021/op400245s · Cited by 151
Almansa, C., Mercè, R., Tesson, N., Farran, J., Tomàs, J., & Plata‐Saláman, C. R. (2017) · Crystal Growth & Design · doi:10.1021/acs.cgd.6b01848 · Cited by 151
Dissolution process analysis using model-free Noyes–Whitney integral equation
Hattori, Y., Haruna, Y., & Otsuka, M. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.08.017 · Cited by 146
Engineering of Pharmaceutical Materials: An Industrial Perspective
Chow, K., Tong, H. H. Y., Lum, S., & Chow, A. H. L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21212 · Cited by 146
Ross, S. A., Lamprou, D. A., & Douroumis, D. (2016) · Chemical Communications · doi:10.1039/c6cc01289b · Cited by 141
Jensen, K. T., Löbmann, K., Rades, T., & Grohganz, H. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6030416 · Cited by 136
Developing Nanocrystals for Cancer Treatment
Lü, Y., Chen, Y., Gemeinhart, R. A., Wu, W., & Li, T. (2015) · Nanomedicine · doi:10.2217/nnm.15.73 · Cited by 135
Fast dissolving eutectic compositions of two anti-tubercular drugs
Cherukuvada, S., & Nangia, A. K. (2012) · CrystEngComm · doi:10.1039/c2ce06391c · Cited by 129
Self-citationCocrystals of the Tuberculosis Drug Isoniazid: Polymorphism, Isostructurality, and Stability
Swapna, B., Maddileti, D., & Nangia, A. K. (2014) · Crystal Growth & Design · doi:10.1021/cg501182t · Cited by 119
Self-citationAdvanced Continuous Flow Platform for On‐Demand Pharmaceutical Manufacturing
Zhang, P., Weeranoppanant, N., Thomas, D. A., Tahara, K., Stelzer, T., Russell, M. G., O’Mahony, M. A., Myerson, A. S., Lin, H., Kelly, L. P., et al. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201706004 · Cited by 112
Ma, Y., Wu, S., Macaringue, E. G. J., Zhang, T., Gong, J., & Wang, J. (2020) · Organic Process Research & Development · doi:10.1021/acs.oprd.9b00362 · Cited by 109
Gopi, S. P., Ganguly, S., & Desiraju, G. R. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00320 · Cited by 106
The a to Z of Pharmaceutical Cocrystals: A Decade of Fast-Moving New Science and Patents
Almarsson, Ö., Peterson, M. L., & Zaworotko, M. J. (2012) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.12.29 · Cited by 101
Solubility Advantage of Tenoxicam Phenolic Cocrystals Compared to Salts
Bolla, G., Sanphui, P., & Nangia, A. K. (2013) · Crystal Growth & Design · doi:10.1021/cg4000457 · Cited by 100
Self-citationA nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein
Pi, J., Wang, S., Wen, L., Kebebe, D., Zhang, Y., Zhang, B., Qi, D., Guo, P., Li, N., & Liu, Z. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2018.04.009 · Cited by 100
Li, Z., & Matzger, A. J. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00843 · Cited by 99
Wang, J., Dai, X.-L., Lu, T., & Chen, J. (2021) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c01153 · Cited by 95
Pharmaceutical Nano‐Cocrystals: Sonochemical Synthesis by Solvent Selection and Use of a Surfactant
Sander, J. R. G., Bučar, D., Henry, R. F., Zhang, G. G. Z., & MacGillivray, L. R. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002588 · Cited by 94
Rajput, L., Banik, M., Yarava, J. R., Joseph, S., Pandey, M. K., Nishiyama, Y., & Desiraju, G. R. (2017) · IUCrJ · doi:10.1107/s205225251700687x · Cited by 92
The Medicinal Chemistry of Imidazotetrazine Prodrugs
Moody, C., & Wheelhouse, R. T. (2014) · Pharmaceuticals · doi:10.3390/ph7070797 · Cited by 88
A novel curcumin–artemisinin coamorphous solid: physical properties and pharmacokinetic profile
Suresh, K., Mannava, M. K. C., & Nangia, A. K. (2014) · RSC Advances · doi:10.1039/c4ra11935e · Cited by 88
Self-citationMohammady, M., Mohammadi, Y., & Yousefi, G. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.07.015 · Cited by 87
Bommaka, M. K., Mannava, M. K. C., Suresh, K., Gunnam, A., & Nangia, A. K. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b00921 · Cited by 84
Self-citationOrganic–inorganic ionic co-crystals: a new class of multipurpose compounds
Braga, D., Grepioni, F., & Shemchuk, O. (2018) · CrystEngComm · doi:10.1039/c8ce00304a · Cited by 83
Solubility and Stability Advantages of a New Cocrystal of Berberine Chloride with Fumaric Acid
Yang, D., Cao, J., Jiao, L.-T., Yang, S., Zhang, L., Lü, Y., & Du, G. (2020) · ACS Omega · doi:10.1021/acsomega.0c00692 · Cited by 82
Smith, A. J., Kavuru, P., Arora, K. K., Kesani, S., Tan, J., Zaworotko, M. J., & Shytle, R. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4000794 · Cited by 81
Redefining the Term of “Cocrystal” and Broadening Its Intention
Zhang, C., Xiong, Y., Jiao, F., et al. (2019) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b01537 · Cited by 80
Arzi, R. S., & Sosnik, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.012 · Cited by 78
New Solid Forms of the Anti-HIV Drug Etravirine: Salts, Cocrystals, and Solubility
Rajput, L., Sanphui, P., & Desiraju, G. R. (2013) · Crystal Growth & Design · doi:10.1021/cg4007058 · Cited by 76
Highly soluble olanzapinium maleate crystalline salts
Thakuria, R., & Nangia, A. K. (2011) · CrystEngComm · doi:10.1039/c0ce00787k · Cited by 75
Self-citationKarashima, M., Kimoto, K., Yamamoto, K., Kojima, T., & Ikeda, Y. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.006 · Cited by 73
Aitipamula, S., & Vangala, V. R. (2017) · Journal of the Indian Institute of Science · doi:10.1007/s41745-017-0026-4 · Cited by 73
Survey and analysis of crystal polymorphism in organic structures
Kersten, K. M., Kaur, R., & Matzger, A. J. (2018) · IUCrJ · doi:10.1107/s2052252518000660 · Cited by 72
Ionic Liquids in Drug Delivery
Pedro, S. N., Freire, C. S. R., Silvestre, A. J. D., & Freire, M. G. (2021) · Encyclopedia · doi:10.3390/encyclopedia1020027 · Cited by 72
Can We Identify the Salt–Cocrystal Continuum State Using XPS?
Tothadi, S., Shaikh, T. R., Gupta, S., Dandela, R., Vinod, C. P., & Nangia, A. K. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c00661 · Cited by 70
Self-citationAndrographolide: Solving Chemical Instability and Poor Solubility by Means of Cocrystals
Suresh, K., Goud, N. R., & Nangia, A. K. (2013) · Chemistry - An Asian Journal · doi:10.1002/asia.201300859 · Cited by 67
Self-citationSanphui, P., Bolla, G., Nangia, A. K., & Chernyshev, V. V. (2014) · IUCrJ · doi:10.1107/s2052252514004229 · Cited by 67
Self-citationEnhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation
Mannava, M. K. C., Gunnam, A., Lodagekar, A., Shastri, N. R., Nangia, A. K., & Solomon, K. A. (2020) · CrystEngComm · doi:10.1039/d0ce01316a · Cited by 67
Self-citationNarala, S., Nyavanandi, D., Srinivasan, P., Mandati, P., Bandari, S., & Repka, M. A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102209 · Cited by 62
Drug–drug co-crystallization presents a new opportunity for the development of stable vitamins
Wang, J., Yu, Q., Dai, W., & Mei, X. (2016) · Chemical Communications · doi:10.1039/c5cc10297a · Cited by 61
Xiao, Y., Zhou, L. Y., Hao, H., Bao, Y., Yin, Q., & Xie, C. (2021) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c01519 · Cited by 61
Synthetic Approaches to Halogen Bonded Ternary Cocrystals
Jain, H., Sutradhar, D., Roy, S., & Desiraju, G. R. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202103516 · Cited by 58
Production of cocrystals in an excipient matrix by spray drying
Walsh, D. P., Serrano, D. R., Worku, Z. A., Norris, B. A., & Healy, A. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.020 · Cited by 54
Raatikainen, K., Cametti, M., & Rissanen, K. T. (2010) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.6.4 · Cited by 53
Pharmaceutical Cocrystals: A Novel Approach for Oral Bioavailability Enhancement of Drugs
Chadha, R., Saini, A., Arora, P., & Bhandari, S. (2012) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v29.i3.10 · Cited by 52
Salts, Cocrystals, and Ionic Cocrystals of a “Simple” Tautomeric Compound
Wang, T., Stevens, J. S., Vetter, T., Whitehead, G. F. S., Vitórica‐Yrezábal, Í. J., Hao, H., & Cabeza, A. J. C. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b01159 · Cited by 52
Swapna, B., Mannava, M. K. C., & Nangia, A. K. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.02.014 · Cited by 51
Self-citationGamboa, A., Schüßler, N., Soto‐Bustamante, E., Romero-Hasler, P., Meinel, L., & Morales, J. O. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.09.007 · Cited by 51
Cocrystal Engineering of Itraconazole with Suberic Acid via Rotary Evaporation and Spray Drying
Weng, J., Wong, S. N., Xu, X., Xuan, B., Wang, C., Chen, R., Sun, C. C., Lakerveld, R., Kwok, P. C. L., & Chow, S. F. (2019) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b01873 · Cited by 49
Switching polymorph stabilities with impurities provides a thermodynamic route to benzamide form III
Kras, W., Carletta, A., Montis, R., Sullivan, R. A. L., & Cabeza, A. J. C. (2021) · Communications Chemistry · doi:10.1038/s42004-021-00473-7 · Cited by 49
de Waard, H., Beer, T. D., Hinrichs, W. L. J., Vervaet, C., Remon, J., & Frijlink, H. W. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9215-z · Cited by 48
The generation of myricetin–nicotinamide nanococrystals by top down and bottom up technologies
Liu, M., Hong, C., Li, G., Ma, P., & Xie, Y. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/39/395601 · Cited by 47
Pugliese, A., Toresco, M., McNamara, D. P., Iuga, D., Abraham, A., Tobyn, M., Hawarden, L. E., & Blanc, F. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00427 · Cited by 46
Cocrystals, Salts, and Supramolecular Gels of Nonsteroidal Anti-Inflammatory Drug Niflumic Acid
Mittapalli, S., Mannava, M. K. C., Sahoo, R., & Nangia, A. K. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b01298 · Cited by 44
Self-citationUnderstanding the Formation of Indomethacin–Saccharin Cocrystals by Anti-Solvent Crystallization
Lee, M., Chun, N.-H., Wang, I.-C., Liu, J. J., Jeong, M.-Y., & Choi, G. J. (2013) · Crystal Growth & Design · doi:10.1021/cg400135a · Cited by 43
On behalf of the Co-Crystal of Tramadol-Celecoxib Team, López-Cedrún, J. L., Videla, S., Burgueño, M., Escalona, I. J., Centenero, S. A.-H., Martín-Granizo, R., Grau, J., Puche, M., Gil-Díez, J. L., et al. (2018) · Drugs in R&D · doi:10.1007/s40268-018-0235-y · Cited by 43
Lee, T., Chen, H. R., Lin, H. Y., & Lee, H. L. (2012) · Crystal Growth & Design · doi:10.1021/cg300763t · Cited by 42
Li, S., Yu, T., Tian, Y., Lagan, C., Jones, D. S., & Andrews, G. P. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00979 · Cited by 42
Data mining of solubility parameters for computational prediction of drug–excipient miscibility
Alhalaweh, A., Alzghoul, A. M., & Kaialy, W. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.789906 · Cited by 41
Shi, V. C., Senni, M., Streefkerk, H. J., Modgill, V., Zhou, W., & Kaplan, A. P. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.121 · Cited by 41
Edwards, P. T., Saunders, L. K., Pallipurath, A. R., Britton, A. J., Willneff, E. A., Shotton, E. J., & Schroeder, S. L. M. (2021) · Crystal Growth & Design · doi:10.1021/acs.cgd.1c00807 · Cited by 41
Zhang, L., Kong, D., Wang, H., Jiao, L.-T., Zhao, X., Song, J., Yang, D., Yang, H., Yang, S., Du, G., et al. (2021) · Molecules · doi:10.3390/molecules26092677 · Cited by 39
Choquesillo‐Lazarte, D., Nemec, V., & Cinčić, D. (2017) · CrystEngComm · doi:10.1039/c7ce01252g · Cited by 38
Continuum Crystallization Model Derived from Pharmaceutical Crystallization Mechanisms
Tsarfati, Y., Biran, I., Wiedenbeck, E., Houben, L., Cölfen, H., & Rybtchinski, B. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00254 · Cited by 38
Effect of inductive effect on the formation of cocrystals and eutectics
Karothu, D. P., Cherukuvada, S., Stephen, L. D., & Row, T. N. G. (2014) · CrystEngComm · doi:10.1039/c4ce01489h · Cited by 35
Terahertz spectroscopy to identify the polymorphs in freeze-dried mannitol
Chakkittakandy, R., Corver, J. A. W. M., & Planken, P. C. M. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21870 · Cited by 35
Nugrahani, I., & Auli, W. N. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04864 · Cited by 34
Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study
Cebrecos, J., Carlson, J. D., Encina, G., Lahjou, M., Sans, A., Sust, M., Vaqué, A., Morte, A., Gascón, N., & Plata‐Saláman, C. R. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.04.002 · Cited by 34
Tuning mechanical behaviour by controlling the structure of a series of theophylline co-crystals
Kakkar, S., Bhattacharya, B., Reddy, C. M., & Ghosh, S. (2018) · CrystEngComm · doi:10.1039/c7ce01915g · Cited by 33
Ketkar, S., Pagire, S. K., Goud, N. R., Mahadik, K. R., Nangia, A. K., & Paradkar, A. R. (2016) · Crystal Growth & Design · doi:10.1021/acs.cgd.6b00759 · Cited by 31
Self-citationMahieux, J., Gonella, S., Sanselme, M., & Coquerel, G. (2011) · CrystEngComm · doi:10.1039/c1ce05484h · Cited by 30
Mannava, M. K. C., Bommaka, M. K., Dandela, R., Solomon, K. A., & Nangia, A. K. (2022) · Chemical Communications · doi:10.1039/d1cc07187d · Cited by 28
Self-citationCrystal growth by nonaqueous gel diffusion
Desiraju, G. R., Curtin, D. Y., & Paul, I. C. (1977) · Journal of the American Chemical Society · doi:10.1021/ja00460a075 · Cited by 27
A multi-step continuous flow synthesis of the cystic fibrosis medicine ivacaftor
Vasudevan, N., Sharma, M. K., Reddy, D. S., & Kulkarni, A. A. (2018) · Reaction Chemistry & Engineering · doi:10.1039/c8re00025e · Cited by 26
Crystal structures of mirtazapine molecular salts
Sarma, B., Thakuria, R., Nath, N. K., & Nangia, A. K. (2011) · CrystEngComm · doi:10.1039/c0ce00746c · Cited by 25
Self-citationCoprocessing of Pharmaceutical Cocrystals for High Quality and Enhanced Physicochemical Stability
Ross, S. A., Ward, A., Basford, P., McAllister, M. S., & Douroumis, D. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b01440 · Cited by 23
Seera, R., Cherukuvada, S., & Row, T. N. G. (2021) · Crystal Growth & Design · doi:10.1021/acs.cgd.1c00458 · Cited by 18
Alkhidir, T., Saeed, Z. M., Shunnar, A. F., et al. (2021) · Crystal Growth & Design · doi:10.1021/acs.cgd.1c01107 · Cited by 14
Crystal engineering and pharmaceutical crystallization
Bolla, G., Sarma, B., & Nangia, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818192-8.00004-4 · Cited by 13
Self-citationStirk, A. J., Souza, F. E. S., Gerster, J., Mir, F. M., Karadeolian, A., & Rey, A. W. (2021) · Green Chemistry · doi:10.1039/d1gc03683a · Cited by 12
Cocrystallization Tailoring Multiple Radiative Decay Pathways for Amplified Spontaneous Emission
Bolla, G., Liao, Q., Amirjalayer, S., Tu, Z., Lv, S., Liu, J., Zhang, S., Zhen, Y., Yi, Y., Liu, X., et al. (2020) · Angewandte Chemie · doi:10.1002/ange.202007655 · Cited by 9
Self-citationAakeröy, C. B., & Đaković, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818192-8.00003-2 · Cited by 6
Cited by
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Metadata
- Authors
- Bolla, G., Sarma, B., & Nangia, A. K.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-06-01
- Volume
- 122
- Issue
- 13
- Pages
- 11514-11603
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W4281730893
- Cited by
- 597
- References
- 175
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.